Dr. Reddy's Laboratories Limited Price, Chart & Factor Exposure
Free Data & Analytics AccessNext earnings: Thu, Jan 21, 2027, before the market opens · estimates and history
Dr. Reddy's Laboratories Limited Forecast
Dr. Reddy's Laboratories Limited short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 29.1% a year, a typical one-standard-deviation range is 1,287–1,397 over a week, 1,229–1,455 over a month and 951.47–1,733 over a year. (Signals as of 5 Nov 2026.)
Dr. Reddy's Laboratories Limited Price Chart
Dr. Reddy's Laboratories Limited Factors
YoY +125.7%
YoY +11.7%
YoY 0.0%
YoY +67.6%
YoY +12.6%
YoY −51.4%
YoY −55.7%
YoY −53.6%
YoY +7.7%
YoY −64.9%
YoY −45.9%
YoY +4.0%
YoY +3.8%
YoY −62.7%
YoY +14.6%
YoY +25.0%
YoY −1.8%
Dr. Reddy's Laboratories Limited fundamentals: income statement, balance sheet & cash flow
Dr. Reddy's Laboratories Limited reported revenue of 335.93bn INR and net income of 42.85bn INR in FY2026, the year ended 31 March 2026 — revenue up 3.2% and net income down 24.2% on the prior year. Free cash flow was 30.51bn INR. These figures are as reported in the filings, not restated: 26 fiscal years and 102 quarters of history, back to March 2001.
| INR billions | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Revenue | 335.93 | 325.54 | 279.16 | 245.88 | 214.39 |
| Cost of revenue | 158.67 | 135.11 | 115.56 | 106.54 | 100.55 |
| Gross profit | 177.26 | 190.43 | 163.61 | 139.34 | 113.84 |
| Research & development | 24.06 | 27.38 | 22.87 | 19.38 | 17.48 |
| Operating income | 46.44 | 71.84 | 67.73 | 57.14 | 29.48 |
| EBITDA | 79.16 | 90.09 | 80.43 | 65.92 | 47.74 |
| Interest expense | 3.74 | 2.83 | 1.71 | 1.43 | 0.96 |
| Pre-tax income | 54.82 | 76.78 | 71.87 | 60.37 | 32.30 |
| Income tax | 12.35 | 19.54 | 16.19 | 15.30 | 8.73 |
| Net income | 42.85 | 56.54 | 55.68 | 45.07 | 23.57 |
Download Dr. Reddy's Laboratories Limited fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.DRREDDY.NSE&statement=all&freq=a&format=csv&years=10
Figures in INR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.
Research on Dr. Reddy's Laboratories Limited
Explore MacroFinance macro & markets research and analysis.
Dr. Reddy's Laboratories Limited Trading Strategies
28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Dr. Reddy's Laboratories Limited; 2 of them are invested now. Strategies currently invested are listed first.
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow Dr. Reddy's Laboratories Limited’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Dr. Reddy's Laboratories Limited (India)
Dr. Reddy's Laboratories Limited is a listed security in India. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
Frequently asked questions
What is Dr. Reddy's Laboratories Limited?
What is the latest Dr. Reddy's Laboratories Limited price?
Is Dr. Reddy's Laboratories Limited in an uptrend?
How volatile is Dr. Reddy's Laboratories Limited?
What factors affect Dr. Reddy's Laboratories Limited?
Which trading strategies trade Dr. Reddy's Laboratories Limited?
How are Dr. Reddy's Laboratories Limited returns analysed?
Where can I download free Dr. Reddy's Laboratories Limited historical data?
Free Dr. Reddy's Laboratories Limited historical data (last 10 years)
Browse or instantly download the last 10 years of Dr. Reddy's Laboratories Limited daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.DRREDDY.NSE&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 1390.2 |
| 2026-11-19 | 1400.9 |
| 2026-11-18 | 1398.2 |
| 2026-11-17 | 1388 |
| 2026-11-16 | 1377.9 |
| 2026-11-13 | 1380 |
| 2026-11-12 | 1386.6 |
| 2026-11-11 | 1377 |
| 2026-11-09 | 1385 |
| 2026-11-08 | 1370 |
About this stock
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.